This healthcare juggernaut's recent quarterly results prove just how strong its business is.
Both of these stocks look like bargains right now.
Abiomed (Nasdaq: ABMD) announces the United States Food and Drug Administration (FDA) has approved the version of Impella ECP that will be used in the Impella ECP Pivotal Trial, and the first two patients...
Even if interest rates go up, you likely won't need to worry about these stocks.
The investments you make now could power your portfolio returns for years to come.
/PRNewswire/ -- S&P MidCap 400 constituent Steel Dynamics Inc. (NASD:STLD) will replace Abiomed Inc. (NASD:ABMD) in the S&P 500 and Super Micro Computer Inc....
There's a lot more ahead for these market giants.
No matter how much changes, these two healthcare giants keep performing.
Johnson & Johnson (NYSE: JNJ), the world’s largest, most diversified healthcare products company, today announced that Athos Merger Sub, Inc. (“Offeror”), a wholly owned subsidiary of Johnson & Johnson,...
Large-cap pharmaceuticals Pfizer and Johnson & Johnson are outperforming the broader market in the past year, particularly in the past three months.